Renaissance Technologies LLC Has $1.55 Million Position in Electromed, Inc. (NYSE:ELMD)

Renaissance Technologies LLC raised its holdings in Electromed, Inc. (NYSE:ELMD) by 4.8% in the second quarter, Holdings Channel.com reports. The fund owned 103,004 shares of the company’s stock after acquiring an additional 4,736 shares during the quarter. Renaissance Technologies LLC’s holdings in Electromed were worth $1,548,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Morgan Dempsey Capital Management LLC acquired a new stake in shares of Electromed in the 2nd quarter valued at $108,000. Aristides Capital LLC lifted its position in shares of Electromed by 22.1% in the first quarter. Aristides Capital LLC now owns 24,917 shares of the company’s stock worth $402,000 after buying an additional 4,517 shares during the last quarter. Gabelli Funds LLC lifted its position in shares of Electromed by 76.1% in the first quarter. Gabelli Funds LLC now owns 35,867 shares of the company’s stock worth $579,000 after buying an additional 15,500 shares during the last quarter. Hunter Associates Investment Management LLC increased its holdings in shares of Electromed by 7.1% during the 1st quarter. Hunter Associates Investment Management LLC now owns 86,200 shares of the company’s stock valued at $1,391,000 after acquiring an additional 5,700 shares during the last quarter. Finally, Gamco Investors INC. ET AL raised its stake in shares of Electromed by 32.6% in the 1st quarter. Gamco Investors INC. ET AL now owns 111,356 shares of the company’s stock valued at $1,798,000 after acquiring an additional 27,356 shares in the last quarter. 40.82% of the stock is owned by institutional investors.

Electromed Stock Down 1.0 %

Shares of Electromed stock opened at $21.61 on Friday. Electromed, Inc. has a 12-month low of $9.53 and a 12-month high of $22.23. The stock has a 50 day moving average price of $17.22 and a two-hundred day moving average price of $16.14. The stock has a market capitalization of $187.06 million, a P/E ratio of 43.22 and a beta of 0.27.

Electromed (NYSE:ELMD) last posted its earnings results on Tuesday, August 27th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.06. The business had revenue of $14.83 million for the quarter. Electromed had a net margin of 9.41% and a return on equity of 12.44%.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.